One can only imagine how anxious yesterday’s news of a possible link to cancer must have left people taking cholesterol-lowering drugs. With the publication of the results of the 5-year SEAS trial (Simvastatin and Ezetimibe in Aortic Stenosis), arguments have been vehemently made on both sides of cancer risks, making things even more confusing. But no one is arguing about two things. No one
